News | Published:

The search beyond statins

Nature Medicine volume 16, pages 150153 (2010) | Download Citation

Statin drugs have made history for their blockbuster sales, and their use is only expected to increase when Lipitor's patent soon expires. But, for millions of people, statins simply don't do enough. Melinda Wenner Moyer explores ongoing efforts to develop new cholesterol-lowering drugs in light of clues that cardiovascular health is more complicated than doctors once thought.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Author information


  1. Melinda Wenner Moyer is a science writer based in Brooklyn, New York. Her LDL cholesterol level is normal.

    • Melinda Wenner Moyer


  1. Search for Melinda Wenner Moyer in:

About this article

Publication history



Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing